Market Share of Global Cervical Cancer Diagnostics and Therapeutics Industry
The Cervical Cancer Diagnostics and Therapeutics Market is fragmented, competitive, and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Companies are currently focusing on developing advanced techniques for diagnosis, such as liquid-based cytology. Some of the companies currently dominating the market are Abbott Laboratories, Bristol-Myers Squibb Company, GlaxoSmithKline PLC, Merck & Co. Inc., Pfizer Inc., Qiagen NV, Advaxis Inc., Becton, Dickinson and Company, and F. Hoffmann-La Roche Ltd.
Cervical Cancer Diagnostics and Therapeutics Market Leaders
Novartis AG
Becton, Dickinson and Company
Abbott Laboratories
F. Hoffman-La Roche Ltd
GlaxoSmithKline Plc
*Disclaimer: Major Players sorted in no particular order
